VASOPLEGIC SHOCK

Clinical trials for VASOPLEGIC SHOCK explained in plain language.

Never miss a new study

Get alerted when new VASOPLEGIC SHOCK trials appear

Sign up with your email to follow new studies for VASOPLEGIC SHOCK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for heart bypass patients: drug targets dangerous low blood pressure

Disease control Not yet recruiting

This study tests a drug called Angiotensin II for patients who develop dangerously low blood pressure after heart bypass surgery. About 329 adults will receive the drug along with standard treatments, and their outcomes will be compared to similar patients from the past. The goal…

Matched conditions: VASOPLEGIC SHOCK

Phase: PHASE4 • Sponsor: Methodist Healthcare System of San Antonio • Aim: Disease control

Last updated Jun 28, 2026 00:00 UTC

VASOPLEGIC SHOCK

Get alerted when new VASOPLEGIC SHOCK trials appear

New hope for heart bypass patients: drug targets dangerous low blood pressure